OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
Cosmo Del Borgo, Silvio Garattini, Carolina Bortignon, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1025-1025
Open Access | Times Cited: 13
Cosmo Del Borgo, Silvio Garattini, Carolina Bortignon, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1025-1025
Open Access | Times Cited: 13
Showing 13 citing articles:
Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation
Wang Chun Kwok, Terence Chi Chun Tam, Jcm Ho, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 77-86
Open Access | Times Cited: 3
Wang Chun Kwok, Terence Chi Chun Tam, Jcm Ho, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 77-86
Open Access | Times Cited: 3
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study
Andrea De Vito, Giulia Moi, Laura Saderi, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2180-2180
Open Access | Times Cited: 7
Andrea De Vito, Giulia Moi, Laura Saderi, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2180-2180
Open Access | Times Cited: 7
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 1
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 1
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access
Effects of Infliximab on patients with COVID-19: a systematic review and meta-analysis
A Ataei, Amirhossein Orandi, Ebadallah Shiri Malekabad, et al.
Authorea (Authorea) (2024)
Open Access
A Ataei, Amirhossein Orandi, Ebadallah Shiri Malekabad, et al.
Authorea (Authorea) (2024)
Open Access
Remdesivir and Nirmatrelvir Show Consistent Synergistic Efficacy Across Ancestral and Newly Emerged Sars-Cov-2 Clinical Isolates
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
(2024)
Closed Access
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
(2024)
Closed Access
Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study
Eric Yuk Fai Wan, Zoey C. T. Wong, Vincent Ka Chun Yan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4653-4664
Closed Access
Eric Yuk Fai Wan, Zoey C. T. Wong, Vincent Ka Chun Yan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4653-4664
Closed Access
In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2
Mohd Ridzuan Mohd Abd Razak, Nur Hana Md Jelas, Nor Azrina Norahmad, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access
Mohd Ridzuan Mohd Abd Razak, Nur Hana Md Jelas, Nor Azrina Norahmad, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access
Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
COVID-19 residual symptoms and adverse drug reactions after oral antiviral therapy in the Singapore primary care setting
Jia Qi Yeo, Poh Ching Tan, Cheng Tan, et al.
Annals of the Academy of Medicine Singapore (2024) Vol. 53, Iss. 12, pp. 762-764
Open Access
Jia Qi Yeo, Poh Ching Tan, Cheng Tan, et al.
Annals of the Academy of Medicine Singapore (2024) Vol. 53, Iss. 12, pp. 762-764
Open Access
Special Issue “Efficacy and Safety of Antiviral Therapy”
Agnese Colpani, Andrea De Vito, Giordano Madeddu
Viruses (2023) Vol. 15, Iss. 7, pp. 1411-1411
Open Access
Agnese Colpani, Andrea De Vito, Giordano Madeddu
Viruses (2023) Vol. 15, Iss. 7, pp. 1411-1411
Open Access
